Skip to content

Study on the Application of Covered Intestinal Stents in Percutaneous Transhepatic Choledochoscopy

Study on the Application of Covered Intestinal Stents in Percutaneous Transhepatic Choledochoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117780
Enrollment
Unknown
Registered
2026-01-28
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bilioenteric anastomotic strictures

Interventions

PTCS group:Dilation of the anastomosis using a covered enteral stent via percutaneous transhepatic cholangioscopy (PTCS) in patients with bilioenteric anastomotic stricture.

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Previously underwent Roux-en-Y choledochojejunostomy; 2. The patient is diagnosed with benign stricture at the biliary-enteric anastomosis. The diagnosis is based on preoperative MRCP and intraoperative cholangiography or direct endoscopic visualization showing biliary stricture, combined with clinical symptoms such as jaundice, fever, abdominal pain, liver function abnormalities including elevated bilirubin and alkaline phosphatase, and abdominal ultrasound indicating bile duct dilation; 3. Age between 18 and 85 years; 4. General condition is good, without significant organic disease or functional impairment, able to tolerate general anesthesia; 5. Preoperative liver function is Child-Pugh class A or B; 6. The patient and family are informed and agree to PTCS treatment for the biliary stricture.

Exclusion criteria

Exclusion criteria: 1. Patients with acute biliary tract infection requiring emergency surgery; 2. Patients with absolute contraindications to PTCS/ERCP; 3. Pregnant or breastfeeding women; 4. Severe coagulation disorders: any of the following abnormalities – International Normalized Ratio (INR) >= 1.5, prothrombin time > 17 s, or platelet count <= 50×10^9/L.

Design outcomes

Primary

MeasureTime frame
clinical success rate;Perioperative mortality rate;

Secondary

MeasureTime frame
Hospital stay;Duration of the operation;Survival rate;surgical complication;Technical success rate;Recurrence rate of stenosis;

Countries

China

Contacts

Public ContactRongxing Zhou

West China Hospital, Sichuan University

rongxingzhou@126.com+86 189 8060 2218

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026